Nov 20, 2024, 15:19 | Insight

Eric Lim: Immunotherapy - before, after or both?

Eric Lim, Professor of Thoracic Surgery at Royal Brompton Hospital, shared his recent article on…

Nov 19, 2024, 20:55 | Blog

Rawia Mohamed: Updates and Insights on MMR in Colorectal Cancer

Rawia Mohamed, Head of the Anatomical Pathology Department at Burjeel Medical City, shared a post…

Nov 19, 2024, 20:50 | Blog

What a Ph.D. student needs to know about Cancer Immunology and Immunotherapy - CCIT-DK

CCIT-DK - National Center for Cancer Immune Therapy of Denmark shared a post on LinkedIn: “What…

Nov 19, 2024, 20:48 | Insight

Jun Gong: ctDNA-guided adjuvant immunotherapy in stage III MSI-H dMMR colon cancer

Jun Gong, Medical Oncologist and Researcher at Cedars-Sinai Medical Center, shared a post on X…

Nov 19, 2024, 20:44 | Blog

Dhan Chand: Expanding treatment options through innovative iNKT cell therapy combinations

Dhan Chand, Vice President of Research at Agenus, shared a post on LinkedIn: "Novel cell…

Nov 19, 2024, 14:54 | Insight

Sarcopenia and inflammation predict poorer outcomes in Cancer Immunotherapy

George Vlachogiannis, Executive Editor of Cancer Control at Sage Publishing, shared an article by Enes…

Nov 19, 2024, 13:43 | Insight

Highlights from New York Lung Cancers Symposium 2024 by Stephen V Liu

The New York Lung Cancers Symposium 24 (NYLung24) took place on 16th of November 2024,…

Nov 18, 2024, 14:07 | Drugs

IDRx Announces Updated Phase 1 Data from Ongoing Phase 1/1b StrateGIST 1 Trial of IDRX-42

IDRx Announces Updated Phase 1 Data from Ongoing Phase 1/1b StrateGIST 1 Trial of IDRX-42…

Nov 17, 2024, 12:17 | Insight

Jarushka Naidoo: Do we need PCI in SCLC in the IO era?

Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin, shared a post on X about…

Nov 17, 2024, 07:58 | Blog

523 Gene test identifies 67% of patients for Targeted Therapy or Immunotherapy

Bernard A. Fox, Adjunct Professor in the Department of Molecular Microbiology and Immunology at the…

Nov 16, 2024, 15:52 | Insight

Lucjan Wyrwicz: Immunotherapy in cancer is a story of success

Lucjan Wyrwicz, Head of Department, Dept. of Oncology and Radiotherapy at Maria Skłodowska-Curie Memorial Cancer…

Nov 16, 2024, 11:50 | Blog

Sarah Louden: The Power of Comprehensive Genomic Profiling

Sarah Louden, Founder and CEO of Total Health, shared a post on LinkedIn: “To fully disclose, I worked…

Nov 15, 2024, 21:26 | Blog

Johanna Joyce: An inspiring end to our Tumor Immunology and Immunotherapy

Johanna Joyce, Professor at the University of Lausanne and Full Member of the international Ludwig…

Nov 15, 2024, 15:59 | Blog

Shushan Hovsepyan: Can we change the game for sarcoma patients with immunotherapy?

Shushan Hovsepyan shared on LinkedIn: "Can we change the game for sarcoma patients with immunotherapy? Two…

Nov 14, 2024, 17:48 | Blog

Marco Donia: Pleased to be Co-chairing with Timothée Olivier in an educational session at ESMOImmuno24

Marco Donia, Senior Consultant, Clinician-Scientist and Junior Research Group Leader (TIL group) at University of…

Nov 14, 2024, 16:27 | Insight

Jiasen He: Immunotherapy-related neurotoxicity in children with cancer

Jiasen He, Clinical Fellow at the MD Anderson Cancer Center, shared a post on X:…

Nov 14, 2024, 14:40 | Dialogues

Advances in Head and Neck Cancer with Dr. Paolo Bossi | OncoInfluencers

In this episode of OncoDaily, Dr. Paolo Bossi, Associate Professor of Oncology at Humanitas University,…

Nov 14, 2024, 00:05 | Blog

Stephen V Liu: Federico Cappuzzo on perioperative immunotherapy at VIII Thoracic Oncology Conference

Stephen V Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown…

Nov 12, 2024, 13:38 | Blog

Shabnam Eghbali on Metastatic Melanoma treated with IO therapy - Vanderbilt Hem/Onc

Vanderbilt Hem/Onc shared a post on X: "Dr. Shabnam Eghbali, PGY-2, Vanderbilt University Medical Center presented…

Nov 12, 2024, 13:35 | Blog

Petros Grivas: Highlighting Advancement in Immunotherapy and cutting-edge clinical trial innovations

Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…

Nov 12, 2024, 13:24 | Blog

AACR IO Conference on Discovery and Innovation in Cancer Immunology

AACR shared on LinkedIn: “Immunotherapy for cancer has come a long way, [but] it is not…

Nov 12, 2024, 11:04 | Blog

Angela Mastronuzzi: 54th SIN CONGRESS ROME 2024

Angela Mastronuzzi, Pediatric hematologist-oncologist and the Head of Neuro-Oncology Unit at Bambino Gesù Children's Hospital,…

Nov 10, 2024, 10:44 | Insight

Highlights from IKCSNA24: 20 Posts Not to Miss

The 2024 International Kidney Cancer Symposium: North America (IKCSNA24) held from November 7-9, 2024, at…

Nov 10, 2024, 00:33 | Insight

Marwan Fakih: Updated RIN results in MSS chemo-refractory non-liver metastatic colorectal cancer

Marwan Fakih, Associate Director for Clinical Sciences at City of Hope, shared a post on…

Nov 9, 2024, 20:08 | Blog

Dr. Sara Tolaney Discusses ESMO24 Insights on TroFuse-010 Trial in Advanced Breast Cancer

Dana-Farber’s Breast Oncology Center shared the following on X: “Dr. Sara Tolaney discussed ESMO24 Insights…

Nov 9, 2024, 20:04 | Blog

Toni Choueiri on the Flexibility of Therapies Beyond PD-1 Inhibitors

Toni Choueiri, Director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, shared…

Nov 9, 2024, 12:26 | Blog

Jonathan Lim: Join Fiona Thistlethwaite as a Clinical Fellow in Advanced Immunotherapy and Cell Therapy Team

Jonathan Lim, Clinical Senior Lecturer in Cancer Biology the University of Manchester, shared a post…

Nov 9, 2024, 12:04 | Insight

Celebrating 40 Years of TCR Discovery: A Gathering of Giants in T Cell Immunology

This year marks the 40th anniversary of the discovery of the T cell receptor (TCR),…

Nov 8, 2024, 12:37 | Positive

Jennifer Buell: Pioneering Leadership in Biotechnology

Dr. Jennifer Buell is a prominent figure in the biotechnology industry, currently serving as the…

Nov 7, 2024, 15:50 | Insight

Endometrial Cancer Advances - Dana-Farber Cancer Institute

Dana-Farber Cancer Institute shared a post on LinkedIn: "For the past decade, new cases of endometrial…

Nov 7, 2024, 15:07 | Blog

Local control and toxicity after stereotactic radiotherapy in brain metastases patients

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, posted on X about recent…

Nov 5, 2024, 10:35 | Blog

Bristol Myers Squibb Reports Third Quarter Financial Results for 2024

Bristol Myers Squibb's Performance Reflects Continued Focus on Near-Term Execution and Building a Foundation for…

Nov 4, 2024, 15:55 | Insight

Yan Leyfman: An innovative approach to promote CAR T cell longevity and boost therapeutic efficacy

Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn by Francisco…

Nov 4, 2024, 15:50 | Insight

Marwan Fakih: Updated RIN results in MSS chemo-refractory non-liver metastatic colorectal cancer

Marwan Fakih, Associate Director for Clinical Sciences at City of Hope, shared a post on…

Nov 3, 2024, 09:30 | Blog

Hidehito Horinouchi: Proud to be Mentoring Japan's Rising Star Masahiro Torasawa

Hidehito Horinouchi posted on X: "Proud to be Mentoring Japan's Rising Star Masahiro Torasawa Distinguished…

Nov 2, 2024, 17:53 | Blog

Last chance to register for ESMO Asia 2024 at discounted rates

ESMO - European Society for Medical Oncology, shared this post on LinkedIn: "Last chance to…

Nov 2, 2024, 15:51 | Immune Oncology,Immunotherapy

Immunotherapy for Metastatic Colon Cancer: Types, Success Rate, Side Effects & More

Immunotherapy has emerged as a promising treatment option for colon cancer, particularly for patients with…

Nov 2, 2024, 12:52 | Insight

When to stop ICIs in dMMR/MSI-H metastatic colorectal cancer

Thor Halfdanarson, Medical Oncologist and Educator and Professor of Oncology at Mayo Clinic, shared an…

Nov 2, 2024, 03:04 | Blog

Melvin LK Chua: Potential Increased Risks of Toxicities with Combo IO Immunotherapy and RT

Melvin LK Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of…

Nov 1, 2024, 07:21 | Blog

Yaky Yanay: Pluri will be collaborating with BIRAD to advance cancer immunotherapy for solid tumors

Yaky Yanay, CEO and President at Pluri, shared a post by Pluri, on LinkedIn: "I'm happy to…

Nov 1, 2024, 05:42 | Positive

Biden Cancer Moonshot Initiative Awards Over $6 Million to 11 Early-Career Researchers for Innovative Cancer Research

On October 29, 2024, the Biden Cancer Moonshot initiative announced funding for 11 early-career researchers and research…

Nov 1, 2024, 05:37 | Immune Oncology

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Immunotherapy has revolutionized the treatment of melanoma, particularly for advanced or metastatic cases. By harnessing…

Oct 31, 2024, 15:01 | Insight

Clinical targets demonstrating promising activity in SCLC

Jean-Charles Soria, Amgen's Senior vice president of Oncology within Global Development, shared a post by…

Oct 29, 2024, 21:00 | Positive

Steven O'Day: At the Forefront of Immunotherapy

Dr. Steven O'Day, an immunotherapy pioneer and medical oncologist, is the Chief Medical Officer at…

Oct 28, 2024, 10:44 | Blog

Rachael Brown and Scott Glenn bring the experience and passion needed to drive CRI’s next phase of growth and impact

Cancer Research Institute (CRI) shared on Linkedin: ''The Cancer Research Institute is pleased to announce…

Oct 27, 2024, 14:00 | Blog

The potential Antibody Drug Conjugates in solid tumor immunotherapy with Virginia Metrangolo

Virginia Metrangolo, Postdoctoral Researcher at the University of Copenhagen, reshared a post by The Antibody…

Oct 27, 2024, 08:16 | Blog

Anthony Zamora: Proud of Jessica Schmeling’s work on immunology research presented at the 2024 AACR conference

Anthony Zamora, Assistant Professor at the Medical College of Wisconsin, posted the following on LinkedIn:…

Oct 26, 2024, 11:58 | Blog

Jennifer Wargo on immunotherapy and microbiome at ENA Symposium 2024

Paolo Tarantino shared a post on X: ''Wonderful ENA Symposium 2024 keynote lecture on immunotherapy…

Oct 25, 2024, 18:53 | Blog

Matthew Kurian: St. Elizabeth leading the charge for educating healthcare providers in NKY area

Matthew Kurian shared a post on LinkedIn: ''Great to see St. Elizabeth leading the charge…

Oct 25, 2024, 16:34 | Insight

Three decades of pioneering in Immune Oncology - Agenus

Agenus Inc. is a biopharmaceutical company and a prominent leader in the field of immuno-oncology,…

Oct 25, 2024, 13:51 | Blog

Drew Moghanaki: Standard of care for stage III NSCLC remains immunotherapy after CRT

Drew Moghanaki, Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA,…

Oct 25, 2024, 13:37 | Blog

Bringing the Promise of Immunotherapy to More Patients - Cancer Research Institute

Cancer Research Institute shared a post on LinkedIn: "The Cancer Research Institute’s investment in research is…

Oct 25, 2024, 13:07 | Blog

Jedd Wolchok ’87: A Believer From the Start - Cancer Research Institute

Cancer Research Institute (CRI) shared a post on LinkedIn: "For CRI Scientific Advisory Council Associate Director…

Oct 25, 2024, 12:34 | Blog

Find out more about immunotherapy with Agenus

Agenus shared a post on LinkedIn: "Receiving a cancer diagnosis can be overwhelming and filled with…

Oct 23, 2024, 10:00 | Insight

MD Anderson Research Highlights

Featuring novel targets for breast cancer, epigenetic strategies to improve immune responses, a treatment for…

Oct 22, 2024, 14:57 | Insight

Joseph Grossman: Botensilimab is effective against Tumors Poorly Responsive to Conventional Immunotherapy

Joseph Grossman, Vice President of Early Clinical Development at Agenus, shared a post on LinkedIn: "The…

Oct 21, 2024, 12:53 | Insight

Supriya Peshin: Classic debate between Rachna Shroff and Milind Javle on TOPAZ-1study

Supriya Peshin, Internal Medicine Resident at Ballad Health, recently shared a post on X: “Day-2…

Oct 21, 2024, 09:01 | Blog

Matthew Kurian: Incredible experience at the KYSCO Conference

Matthew Kurian shared the following on LinkedIn: “What an incredible experience at the KYSCO Conference this…

Oct 20, 2024, 18:54 | Insight

UCLA: New imaging technique accurately detects aggressive kidney cancer

UCLA investigators found the level of accuracy of the non-invasive method could lead to earlier…

Oct 20, 2024, 10:56 | Insight

Guillermo Villacampa: The safety and efficacy of ADCs with immunotherapy

Guillermo Villacampa, Biostatistician, Vall d´Hebron Institute of Oncology (VHIO), shared a post on X: "Antibody-drug conjugate…

Oct 18, 2024, 12:58 | Blog

Rahul Banerjee: Multicenter description of immune effector cell-associated enterocolitis as a novel toxicity of CAR T-cell therapy in multiple myeloma

Rahul Banerjee shared a post on X, about recent paper published in Blood Cancer Journal:…

Oct 16, 2024, 13:33 | Blog

The importance of skeletal muscle in the outcomes of our individuals with cancer, with the new direction of immunotherapy and CAR T-cell therapy

Sami (Papacek) Mansfield, is the founder of Cancer Wellness for Life shared a post by…

Oct 16, 2024, 11:47 | Blog

Allison Institute Symposium Highlights Spatial Biology Innovations and $5M Donation to Boost Research

The James P. Allison Institute at The University of Texas MD Anderson Cancer Center hosted…

Oct 16, 2024, 00:19 | Blog

A.J. Cimino: Exciting customer interactions at ASTRO 2024

A.J. Cimino, Healthcare Sales Director, Unity MR-linac, at Elekata, Eastern U.S., shared a post on LinkedIn:…

Oct 15, 2024, 12:59 | Blog

Brendon Stiles: We owe it to our patients with EGFR mutations

Brendon Stiles, Professor and Chief, Thoracic Surgery and Surgical Oncology, Montefiore Health System shared a post on…

Oct 14, 2024, 14:37 | Blog

Society for Immunotherapy of Cancer - Experience the latest in Immuno Oncology science at SITC 2024

Society for Immunotherapy of Cancer shared on X: '' Experience the latest in Immuno Oncology…

Oct 14, 2024, 12:57 | Blog

Tanja Obradovic: Genenta Science announces opening of the Temferon trial in mRCC

Tanja Obradovic shared a post on LinkedIn: ''Clinical development landscape in metastatic renal cell carcinoma…

Oct 12, 2024, 22:16 | Insight

Triparna Sen: CD38-mediated immunosuppression as a potential mechanism of tumor cell escape from PDL1 inhibition in SCLC

Triparna Sen, Associate Professor, Icahn School of Medicine at Mount Sinai, shared a post on…

Oct 12, 2024, 16:59 | Blog

Advances in AI applications for analyzing electronic health record data - NCI Physical Sciences

NCI Physical Sciences shared a post on X: "On Oct. 15 at 1:00 pm ET,…

Oct 11, 2024, 21:10 | Blog

Abhishek D. Garg: CD8+T cells in low antigenic tumours and its implications for cancer immunotherapy

Abhishek D. Garg, Head of Laboratory of Cell Stress and Immunity (CSI) at KU Leuven, shared…

Oct 11, 2024, 17:56 | Blog

Gerry Hanna: Patrick Forde's overview on neo-adjuvant immunotherapy studies

Gerry Hanna, Radiation Oncologist at St. James Hospital, Dublin, shared a post on X: "So…

Oct 11, 2024, 13:45 | Blog

Triparna Sen: DDR protein ATR activation enhances immunotherapy in SCLC

Triparna Sen posted the following on X: “Thank you Icahn School of Medicine at Mount…

Oct 10, 2024, 18:40 | Blog

The use of immunotherapy in breast cancer treatment is one of the most significant advancements - Cancer Research Institute

Cancer Research Institute (CRI) posted the following on LinkedIn: “One of the most significant recent…

Oct 10, 2024, 15:57 | Insight

New ESMO Open editorial on Immunotherapy in breast cancer

ESMO Open shared a recent article by Paola Zagami on X: "Immunotherapy in the treatment landscape…

Oct 9, 2024, 10:46 | Blog

Wafik S. El-Deiry: Dr. Vivek Subbiah presents on AI’s impact in oncology research at AACR Grantee Summit

Wafik S. El-Deiry posted the following on LinkedIn: “Dr. Vivek Subbiah gives a fantastic presentation…

Oct 8, 2024, 12:29 | Insight

Valerie Yang: How should patients with advanced mucosal melanoma be treated?

Valerie Yang, Consultant Medical Oncologist, National Cancer Centre Singapore, shared a post on LinkedIn: "In…

Oct 8, 2024, 01:45 | Blog

Stephen V Liu: Jordi Remon discusses perioperative IO for NSCLC at ILCS24

Stephen V Liu shared a post on X: "Dr. Jordi Remon discusses perioperative IO for NSCLC…

Oct 7, 2024, 15:21 | Positive

Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough

Dr. Garo Armen, CEO and Chairman of Agenus Inc., Massachusetts-based leading immuno-oncology biotech, has been…

Oct 7, 2024, 11:49 | Blog

Mohamed Benlazar: The future of immunotherapy for diffuse large B-cell lymphoma

Mohamed Benlazar, Professor of Hematology at Sidi Bel Abbès University Hospital, shared a post on…

Oct 7, 2024, 11:25 | Blog

Jeff Sharman: Reflecting on the incredible progress made in lymphoma research

Jeff Sharman, Medical Director for Hematology Research at US Oncology, shared a post on LinkedIn,…

Oct 7, 2024, 09:11 | Blog

Himil Mahadevia: Our research project was accepted for poster presentation at SITC

Himil Mahadevia, PGY-3 IM resident at UMKC, shared a post on X: "Glad to share our…

Oct 6, 2024, 14:01 | Insight

MD Anderson Research Highlights

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…

Oct 5, 2024, 13:04 | Insight

Highlights from ILCS24 by Stephen V Liu

The 6th International Lung Cancer Summit took place as a hybrid event in Lausanne, Switzerland,…

Oct 4, 2024, 06:03 | Drugs

FDA approved Neoadjuvant/Adjuvant Nivolumab for resectable NSCLC

FDA Approval Introduces New Treatment Options for Adults with Resectable Lung Cancer Lacking Key Genetic…

Oct 2, 2024, 13:06 | Blog

What is the difference between chemotherapy and immunotherapy - CRI

CRI (Cancer Research Institute) shared a post on LinkedIn: ''What is the difference between chemotherapy…

Oct 2, 2024, 12:10 | Dialogues

ASCO24 Updates: Dr. Riya Jayesh Patel on Genomic Signatures and Survival in Cholangiocarcinoma

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Oct 2, 2024, 06:11 | Immune Oncology,Oncolibrary

Targeted Therapy vs Immunotherapy: Which Is Right for You, Key Differences & Similarities

Targeted therapy vs immunotherapy is a big debate and huge advancement in cancer treatment. Targeted…

Oct 1, 2024, 14:50 | Blog

African Cancer CEOs - How data-driven transformations can revolutionize cancer treatment

African Cancer CEOs shared a post on X: ''Laila Hessissen shared her expert on immunotherapy…

Oct 1, 2024, 12:35 | Blog

Vincent Rajkumar: Immunotherapy session makes major advances in CART, bispecifics, and ADC

Vincent Rajkumar shared the following on X: “Immunotherapy session at the Myeloma Society Annual Meeting:…

Oct 1, 2024, 05:00 | Blog,Opinion

Florentia Dimitriou: Pushing forward the boundaries of immunotherapy

Florentia Dimitriou, Postdoctoral and TCI Fellow at MD Anderson Cancer Center, shared a post on X:…

Sep 30, 2024, 17:12 | Blog

Delving into the Latest Advancements in Metastatic Breast Cancer - The Breast Cancer Research Foundation

The Breast Cancer Research Foundation posted the following on LinkedIn: “With Metastatic Breast Cancer Awareness…

Sep 29, 2024, 06:34 | Insight

Picks from Lung Cancer Cocktail With Science by Stephen V Liu

The Lung Cancer Cocktail With Science 2024 conference took place on September 27th in Milan,…

Sep 27, 2024, 16:31 | Insight

Immunotherapy for aggressive breast cancer appears to be effective even without chemotherapy - The Netherlands Cancer Institute

The Netherlands Cancer Institute posted on LinkedIn: "Immunotherapy as a treatment for an aggressive form of…

Sep 27, 2024, 16:02 | Blog

Vivek Subbiah: Accelerating Progress in the Fight Against Cancer

Vivek Subbiah shared a post on LinkedIn: “Accelerating Progress in the Fight Against Cancer. On…

Sep 27, 2024, 14:43 | Dialogues

ASCO24 Updates: Dr. Junaid Arshad - Tadalafil and New Approaches to Gastric Cancer

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Sep 27, 2024, 14:25 | Blog

Join Fraunhofer IZI at the Leipzig Immune Oncology Conference 2024

Florian Lordick, Professor of Medicine at University of Leipzig, shared a post by Fraunhofer IZI, on…

Sep 26, 2024, 15:37 | Blog

Stephen V Liu: Retrospective report on treatment post osimertinib for EGFR NSCLC

Stephen V Liu shared a post on X, about recent paper published in Clinical Lung…

Sep 26, 2024, 13:58 | Blog

Renjith Vijayakumar Selvarani: A Turning Point for Cancer Vaccines

Renjith Vijayakumar Selvarani, Founder, Chairman, Chief Scientific and Technology Officer at OLUSIUM, shared a post…

Sep 24, 2024, 15:15 | Insight

The October issue of Nature Reviews Clinical Oncology

Diana Romero posted on LinkedIn: "The October issue of Nature Reviews Clinical Oncology was just published…

Sep 22, 2024, 12:38 | Blog

Amol Akhade: Cabozantinib plus Atezolizumab vs second-line NHT in prostate cancer

Amol Akhade shared a post on LinkedIn: ''Cabozantinib plus Atezolizumab versus second-line Non-hormonal Therapy (NHT)…